Citations

Showing 10 of 108119 citations.

Alpha‐1 Antitrypsin Deficiency Liver Disease, Mutational Homogeneity Modulated by Epigenetic Heterogeneity With Links to Obesity
Wang, Liguo , Marek, George , Hlady, Ryan A. , Wagner, Ryan T. , Zhao, Xia , Clark, Virginia , Fan, Alex Xiu‐Cheng, Liu, Chen , Robertson, Keith D. , Robertson, Keith D , Wang, Liguo , Liu, Chen , Brantly, Mark

Mayo Clinic

Hepatology | January 25, 2019 | Volume: 70 | Issue: 1 | Pages: 51-66

10.1002/hep.30526 | PMID 30681738 Get It

Alpha‐1 antitrypsin deficiency (AATD) liver disease is characterized by marked heterogeneity in presentation and progression, despite a common underlying gene mutation, strongly suggesting the involvement of other genetic and/or epigenetic modifiers. Variation in clinical phenotype has added to the challenge of detection, diagnosis, and testing of new therapies in patients with AATD. We examined the contribution of DNA methylation (5‐methylcytosine [5mC]) to AATD liver disease heterogeneity because 5mC responds to environmental and genetic cues and its deregulation is a major driver of liver disease. Using liver biopsies from adults with early‐stage AATD and the ZZ genotype, genome‐wide 5mC patterns were interrogated. We compared DNA methylation among patients with early AATD, and among patients with normal liver, cirrhosis, and hepatocellular carcinoma derived from multiple etiologic exposures, and linked patient clinical/demographic features. Global analysis revealed significant genomic hypomethylation in AATD liver–impacting genes related to liver cancer, cell cycle, and fibrosis, as well as key regulatory molecules influencing growth, migration, and immune function. Further analysis indicated that 5mC changes are localized, with hypermethylation occurring within a background of genome‐wide 5mC loss and with patients with AATD manifesting distinct epigenetic landscapes despite their mutational homogeneity. By integrating clinical data with 5mC landscapes, we observed that CpGs differentially methylated among patients with AATD disease are linked to hallmark clinical features of AATD (e.g., hepatocyte degeneration and polymer accumulation) and further reveal links to well‐known sex‐specific effects of liver disease progression. Conclusion: Our data reveal molecular epigenetic signatures within this mutationally homogeneous group that point to ways to stratify patients for liver disease risk.
Generic and Brand-Name Thyroid Hormone Drug Use Among Commercially Insured and Medicare Beneficiaries, 2007 Through 2016
Ross, Joseph S. , Rohde, Stefanie , Sangaralingham, Lindsey R. , Brito, Juan P. , Choi, Lauren , Graham, David J. , Jenkins, Marjorie , Mendoza, Martín, Qiang, Yandong, Wang, Zhong , Wu, Yute, Shah, Nilay D. , Sangaralingham, Lindsey, Yao, Xiaoxi , Ross, Joseph S , Brito, Juan P , Dutcher, Sarah K. , Lipska, Kasia J.

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | January 25, 2019 | Volume: 104 | Issue: 6 | Pages: 2305-2314

10.1210/jc.2018-02197 | PMID 30690529 Get It

Stiffness distribution in the ablated zone after radiofrequency ablation for liver: An ex-vivo study with a tissue elastometer
Li, Xiao‐Long , Liu, Bo-Ji, Chen, Shigao , Li, Dandan , Xu, Hui‐Xiong , Guo, Le‐Hang , Wang, Dan Michelle

Mayo Clinic

Clinical Hemorheology and Microcirculation | January 25, 2019 | Volume: 72 | Issue: 2 | Pages: 151-160

10.3233/ch-180404 | PMID 30689559 Get It

Hospital rules-based system: The next generation of medical informatics for patient safety
Wilson, John , Oyen, Lance J., Ou, Narith N., McMahon, M. Molly , Thompson, Rodney L., Manahan, Janice M., Graner, Kevin, Lovely, Jenna K. , Estes, Lynn L.

Mayo Clinic

American Journal of Health-System Pharmacy | January 25, 2019 | Volume: 62 | Issue: 5 | Pages: 499-505

10.1093/ajhp/62.5.499 | PMID 15745913 Get It

Prospective Evaluation of the St. Jude Medical Aortic Connector for Aortic-to-Autologous Vessel Graft Anastomoses
Diegeler, Anno, Šetina, Marek, Lakew, Fitsum , Mokracek, Alex, Scrofani, Roberto , Eckstein, Friedrich , Gibson, Michael, Bonilla, Luis F., Carrel, Thierry , Antona, Carlo

Mayo Clinic

Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery | January 25, 2019 | Volume: 1 | Issue: 2 | Pages: 79-82

10.1177/155698450500100204 Get It

P413 A simple scoring tool predicts exposure–response relationship, onset of action, response to interval shortening, and surgical risk with vedolizumab therapy for Crohn’s disease
Dulai, Parambir S. , Amiot, Aurélien , Singh, Siddharth , Serrero, Mélanie , Jairath, Vipul , Filippi, Jérôme, Kane, Sunanda V. , Bouhnik, Yoram , Sandborn, William J. , Lasch, Karen, Rosario, Maria , Feagan, Brian G. , Bojic, Daniela, Trang-Poisson, Caroline, Shen, Bo , Altwegg, Romain , Sands, B E, Colombel, J F, Carbonnel, Franck , Bohm, Matthew , Bourrier, Anne, Jairath, Vipul , Jairath, Vipul , Jairath, V , Jairath, V , Jairath, Vipul , Peyrin‐Biroulet, Laurent , Pariente, Benjamin , Loftus, Edward V. , Roblin, Xavier , Buisson, Anthony , Siegel, Corey A , Trang, Caroline , Hudesman, David , Lukin, Dana J.

Mayo Clinic

Journal of Crohn's and Colitis | January 25, 2019 | Volume: 13 | Issue: Supplement_1 | Pages: S316-S316

10.1093/ecco-jcc/jjy222.537 Get It

P435 Rapidity of symptomatic and inflammatory biomarker improvements following upadacitinib induction treatment: data from the U-ACHIEVE study
D’Haens, Geert , Higgins, Peter , Cataldi, Fabio, Lee, W-J, Huang, B , Vermeire, Séverine , Loftus, Edward V. , Panés, Julián , Panaccione, Remo , Zhou, Wen , Lee, W-J, Xie, Wenhui , Vermeire, Séverine

Mayo Clinic

Journal of Crohn's and Colitis | January 25, 2019 | Volume: 13 | Issue: Supplement_1 | Pages: S326-S327

10.1093/ecco-jcc/jjy222.559 Get It

Detection of laryngeal carcinoma in the U.S. elderly population with gastroesophageal reflux disease
Riley, Charles A. , Marino, Michael J. , Hsieh, Mei‐Chin , Wu, Eric , McCoul, Edward D. , McCoul, Edward D , Wu, Xiao‐Cheng

Mayo Clinic

Head & Neck | January 25, 2019 | Volume: 41 | Issue: 5 | Pages: 1434-1440

10.1002/hed.25600 | PMID 30681216 Get It

AbstractBackgroundAn association is suggested between gastroesophageal reflux disease (GERD) or laryngopharyngeal reflux (LPR) and malignancy of the larynx in elderly patients in the United States. Early detection with flexible fiberoptic laryngoscopy (FFL) or CT remains poorly defined.MethodsThe Surveillance, Epidemiology, and End Results (SEER)‐Medicare linked database was queried from 2003 to 2011.A case‐cohort design evaluated patients aged 66 and older with a diagnosis of GERD and/or LPR for the occurrence of FFL or CT within 6 months of the exposure diagnosis.ResultsOf a total 156 426 Medicare beneficiaries, the relative risk of early cancer diagnosis with FFL was 14.61(95% confidence interval [CI], 13.59‐15.70), corresponding to a number needed to detect (NND) a case of cancer of 13(95% CI, 13‐14). The relative risk of an early cancer diagnosis with CT was 31.83 (95% CI, 29.57‐34.26), with a NND of 5 (95% CI, 5‐5).ConclusionsEarly FFL and CT are associated with a higher likelihood of laryngeal cancer diagnosis in elderly individuals with a diagnosis of reflux. Screening trials are necessary to establish this relationship.
P499 Efficacy and safety of 2 or 3 vedolizumab intravenous infusions as induction therapy for ulcerative colitis and Crohn’s disease: results from VISIBLE 1 and 2
Sandborn, William J. , Wolf, Douglas C. , Yao, Xinyi , Kisfalvi, Krisztina, Vermeire, Séverine , Loftus, Edward V. , Danese, Silvio , Chen, Jingjing , Vermeire, Séverine

Mayo Clinic

Journal of Crohn's and Colitis | January 25, 2019 | Volume: 13 | Issue: Supplement_1 | Pages: S361-S362

10.1093/ecco-jcc/jjy222.623 Get It

P258 Abdominal pain and its relationship with clinical outcomes, biomarker levels, and health-related quality of life in patients with moderate to severe ulcerative colitis: data from U-ACHIEVE, a Phase 2b study of upadacitinib
Louis, Édouard , Cataldi, Fabio, Guay, Heath , Lee, W-J, Danese, Silvio , Louis, Edouard , Loftus, Edward V. , Lee, W-J, Ghosh, Subrata

Mayo Clinic

Journal of Crohn's and Colitis | January 25, 2019 | Volume: 13 | Issue: Supplement_1 | Pages: S226-S226

10.1093/ecco-jcc/jjy222.382 Get It